Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
TOLVAPTAN
(2009)
Small molecule
Vasopressin V2 receptor antagonist
ORAL
Approved
Cardiovascular Diseases; Heart Failure; Hyponatremia; Polycystic Kidney Diseases
TOLVAPTAN
×
Maximum Phase:
4
First Approval:
2009
UNII:
21G72T1950
Molecule Type:
Small molecule
Molecular Formula:
C26H25ClN2O3
Molecular Weight:
448.95
AlogP:
5.68
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VIGABATRIN
(2009)
Small molecule
Gamma-amino-N-butyrate transaminase inhibitor
ORAL
Approved
Epilepsy; Epilepsy, Complex Partial; Spasms, Infantile
VIGABATRIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
GR120KRT6K
Molecule Type:
Small molecule
Molecular Formula:
C6H11NO2
Molecular Weight:
129.16
AlogP:
0.36
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BEPOTASTINE
(2009)
Small molecule
Unknown
Unknown
Approved
Unknown
BEPOTASTINE
×
Maximum Phase:
4
First Approval:
2009
UNII:
HYD2U48IAS
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClN2O3
Molecular Weight:
388.9
AlogP:
4.17
PSA:
62.66
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PRASUGREL
(2009)
Small molecule
Unknown
Unknown
Approved
Thrombosis
PRASUGREL
×
Maximum Phase:
4
First Approval:
2009
UNII:
34K66TBT99
Molecule Type:
Small molecule
Molecular Formula:
C20H20FNO3S
Molecular Weight:
373.45
AlogP:
3.89
PSA:
46.61
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PITAVASTATIN CALCIUM
(2009)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Dyslipidemias; Hyperlipidemias
PITAVASTATIN CALCIUM
×
Maximum Phase:
4
First Approval:
2009
UNII:
IYD54XEG3W
Molecule Type:
Small molecule
Molecular Formula:
C50H46CaF2N2O8
Molecular Weight:
881.0
AlogP:
4.52
PSA:
90.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
MILNACIPRAN
(2009)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
MILNACIPRAN
×
Maximum Phase:
4
First Approval:
2009
UNII:
G56VK1HF36
Molecule Type:
Small molecule
Molecular Formula:
C15H22N2O
Molecular Weight:
246.35
AlogP:
1.77
PSA:
46.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FEBUXOSTAT
(2009)
Small molecule
Xanthine dehydrogenase inhibitor
Unknown
Approved
Gout; Hyperuricemia
FEBUXOSTAT
×
Maximum Phase:
4
First Approval:
2009
UNII:
101V0R1N2E
Molecule Type:
Small molecule
Molecular Formula:
C16H16N2O3S
Molecular Weight:
316.38
AlogP:
3.72
PSA:
83.21
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PITAVASTATIN
(2009)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
PITAVASTATIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
M5681Q5F9P
Molecule Type:
Small molecule
Molecular Formula:
C25H24FNO4
Molecular Weight:
421.47
AlogP:
4.52
PSA:
90.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
EVEROLIMUS
(2009)
Small molecule
FK506-binding protein 1A inhibitor
ORAL
Approved
Angiomyolipoma; Astrocytoma; Breast Neoplasms; Carcinoma, Renal Cell; Immune System Diseases; Neoplasms; Neuroendocrine Tumors; Tuberous Sclerosis
EVEROLIMUS
×
Maximum Phase:
4
First Approval:
2009
UNII:
9HW64Q8G6G
Molecule Type:
Small molecule
Molecular Formula:
C53H83NO14
Molecular Weight:
958.24
AlogP:
6.2
PSA:
204.66
HBD:
3.0
HBA:
#RotB:
9.0
Source:
BAZEDOXIFENE ACETATE
(2009)
Small molecule
Estrogen receptor modulator
Unknown
Approved
Osteoporosis, Postmenopausal
BAZEDOXIFENE ACETATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
J70472UD3D
Molecule Type:
Small molecule
Molecular Formula:
C32H38N2O5
Molecular Weight:
530.67
AlogP:
6.33
PSA:
57.86
HBD:
2.0
HBA:
#RotB:
7.0
Source:
OMACETAXINE MEPESUCCINATE
(2009)
Small molecule
Protein synthesis inhibitor
SUBCUTANEOUS
Approved
Neoplasms
OMACETAXINE MEPESUCCINATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
6FG8041S5B
Molecule Type:
Small molecule
Molecular Formula:
C29H39NO9
Molecular Weight:
545.63
AlogP:
2.58
PSA:
123.99
HBD:
2.0
HBA:
#RotB:
9.0
Source:
TELAVANCIN HYDROCHLORIDE
(2009)
Small molecule
Cell outer membrane inhibitor
INTRAVENOUS
Approved
Infections; Pneumonia, Bacterial
TELAVANCIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
0701472ZG0
Molecule Type:
Small molecule
Molecular Formula:
C80H107Cl3N11O27P
Molecular Weight:
1792.12
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BESIFLOXACIN HYDROCHLORIDE
(2009)
Small molecule
Bacterial DNA gyrase inhibitor
OPHTHALMIC
Approved
Conjunctivitis, Bacterial
BESIFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
7506A6J57T
Molecule Type:
Small molecule
Molecular Formula:
C19H22Cl2FN3O3
Molecular Weight:
430.31
AlogP:
3.14
PSA:
88.56
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BENZYL ALCOHOL
(2009)
Small molecule
Unknown
TOPICAL
Approved
Ectoparasitic Infestations; Lice Infestations; Otitis Externa; Pruritus
BENZYL ALCOHOL
×
Maximum Phase:
4
First Approval:
2009
UNII:
LKG8494WBH
Molecule Type:
Small molecule
Molecular Formula:
C7H8O
Molecular Weight:
108.14
AlogP:
1.18
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PRALATREXATE
(2009)
Small molecule
Dihydrofolate reductase inhibitor
INJECTION; INTRAVENOUS
Approved
Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Neoplasms
PRALATREXATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
A8Q8I19Q20
Molecule Type:
Small molecule
Molecular Formula:
C23H23N7O5
Molecular Weight:
477.48
AlogP:
0.98
PSA:
207.3
HBD:
5.0
HBA:
#RotB:
10.0
Source:
ULIPRISTAL ACETATE
(2010)
Small molecule
Progesterone receptor modulator
ORAL
Approved
Unknown
ULIPRISTAL ACETATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
YF7V70N02B
Molecule Type:
Small molecule
Molecular Formula:
C30H37NO4
Molecular Weight:
475.63
AlogP:
5.54
PSA:
63.68
HBD:
0.0
HBA:
#RotB:
4.0
Source:
DABIGATRAN ETEXILATE
(2010)
Small molecule
Unknown
ORAL
Approved
Thrombosis
DABIGATRAN ETEXILATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
2E18WX195X
Molecule Type:
Small molecule
Molecular Formula:
C34H41N7O5
Molecular Weight:
627.75
AlogP:
5.6
PSA:
154.03
HBD:
2.0
HBA:
#RotB:
15.0
Source:
LURASIDONE HYDROCHLORIDE
(2010)
Small molecule
Dopamine D2 receptor antagonist
ORAL
Approved
Bipolar Disorder; Schizophrenia
LURASIDONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2010
UNII:
O0P4I5851I
Molecule Type:
Small molecule
Molecular Formula:
C28H37ClN4O2S
Molecular Weight:
529.15
AlogP:
4.26
PSA:
56.75
HBD:
0.0
HBA:
#RotB:
5.0
Source:
MACITENTAN
(2010)
Small molecule
Endothelin receptor, ET-A/ET-B antagonist
ORAL
Approved
Familial Primary Pulmonary Hypertension; Hypertension
MACITENTAN
×
Maximum Phase:
4
First Approval:
2010
UNII:
Z9K9Y9WMVL
Molecule Type:
Small molecule
Molecular Formula:
C19H20Br2N6O4S
Molecular Weight:
588.28
AlogP:
3.57
PSA:
128.22
HBD:
2.0
HBA:
#RotB:
11.0
Source:
CARGLUMIC ACID
(2010)
Small molecule
Carbamoyl-phosphate synthase [ammonia], mitochondrial positive allosteric modulator
ORAL
Approved
Hyperammonemia
CARGLUMIC ACID
×
Maximum Phase:
4
First Approval:
2010
UNII:
5L0HB4V1EW
Molecule Type:
Small molecule
Molecular Formula:
C6H10N2O5
Molecular Weight:
190.16
AlogP:
-1.03
PSA:
129.72
HBD:
4.0
HBA:
#RotB:
5.0
Source:
DALFAMPRIDINE
(2010)
Small molecule
Voltage-gated potassium channel blocker
ORAL
Approved
Multiple Sclerosis
DALFAMPRIDINE
×
Maximum Phase:
4
First Approval:
2010
UNII:
BH3B64OKL9
Molecule Type:
Small molecule
Molecular Formula:
C5H6N2
Molecular Weight:
94.12
AlogP:
0.66
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
0.0
Source:
LEVOMEFOLIC ACID
(2010)
Small molecule
Unknown
Unknown
Approved
Unknown
LEVOMEFOLIC ACID
×
Maximum Phase:
4
First Approval:
2010
UNII:
8S95DH25XC
Molecule Type:
Small molecule
Molecular Formula:
C20H25N7O6
Molecular Weight:
459.46
AlogP:
-0.26
PSA:
202.77
HBD:
7.0
HBA:
#RotB:
9.0
Source:
FINGOLIMOD
(2010)
Small molecule
Unknown
ORAL
Approved
Immune System Diseases
FINGOLIMOD
×
Maximum Phase:
4
First Approval:
2010
UNII:
3QN8BYN5QF
Molecule Type:
Small molecule
Molecular Formula:
C19H33NO2
Molecular Weight:
307.48
AlogP:
3.2
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
12.0
Source:
LEVOMEFOLATE CALCIUM
(2010)
Small molecule
Unknown
Unknown
Approved
Acne Vulgaris; Anemia, Iron-Deficiency
LEVOMEFOLATE CALCIUM
×
Maximum Phase:
4
First Approval:
2010
UNII:
A9R10K3F2F
Molecule Type:
Small molecule
Molecular Formula:
C20H23CaN7O6
Molecular Weight:
497.53
AlogP:
-0.26
PSA:
202.77
HBD:
7.0
HBA:
#RotB:
9.0
Source:
ERIBULIN MESYLATE
(2010)
Small molecule
Tubulin inhibitor
INTRAVENOUS
Approved
Breast Neoplasms
ERIBULIN MESYLATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
AV9U0660CW
Molecule Type:
Small molecule
Molecular Formula:
C41H63NO14S
Molecular Weight:
826.01
AlogP:
3.44
PSA:
146.39
HBD:
2.0
HBA:
#RotB:
4.0
Source:
HEXAMINOLEVULINATE
(2010)
Small molecule
Unknown
Unknown
Approved
Unknown
HEXAMINOLEVULINATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
G7H20TKI67
Molecule Type:
Small molecule
Molecular Formula:
C11H21NO3
Molecular Weight:
215.29
AlogP:
1.42
PSA:
69.39
HBD:
1.0
HBA:
#RotB:
9.0
Source:
DABIGATRAN ETEXILATE MESYLATE
(2010)
Small molecule
Thrombin inhibitor
Unknown
Approved
Atrial Fibrillation; Embolism; Stroke; Venous Thrombosis
DABIGATRAN ETEXILATE MESYLATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
SC7NUW5IIT
Molecule Type:
Small molecule
Molecular Formula:
C35H45N7O8S
Molecular Weight:
723.85
AlogP:
5.6
PSA:
154.03
HBD:
2.0
HBA:
#RotB:
15.0
Source:
ESTRADIOL VALERATE
(2010)
Small molecule
Estrogen receptor alpha agonist
INJECTION
Approved
Atrophy; Hypogonadism; Menopause; Menorrhagia; Primary Ovarian Insufficiency
ESTRADIOL VALERATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
OKG364O896
Molecule Type:
Small molecule
Molecular Formula:
C23H32O3
Molecular Weight:
356.51
AlogP:
5.35
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
POTASSIUM SULFATE
(2010)
Small molecule
Unknown
Unknown
Approved
Unknown
POTASSIUM SULFATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
1K573LC5TV
Molecule Type:
Small molecule
Molecular Formula:
K2O4S
Molecular Weight:
174.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DIENOGEST
(2010)
Small molecule
Unknown
Unknown
Approved
Menorrhagia
DIENOGEST
×
Maximum Phase:
4
First Approval:
2010
UNII:
46M3EV8HHE
Molecule Type:
Small molecule
Molecular Formula:
C20H25NO2
Molecular Weight:
311.42
AlogP:
3.84
PSA:
61.09
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CEFTAROLINE FOSAMIL
(2010)
Small molecule
Unknown
INTRAVENOUS
Approved
Bacterial Infections
CEFTAROLINE FOSAMIL
×
Maximum Phase:
4
First Approval:
2010
UNII:
7P6FQA5D21
Molecule Type:
Small molecule
Molecular Formula:
C22H21N8O8PS4
Molecular Weight:
684.7
AlogP:
-0.11
PSA:
223.24
HBD:
4.0
HBA:
#RotB:
11.0
Source:
CEFTAROLINE FOSAMIL ACETATE
(2010)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Approved
Kidney Failure, Chronic; Pneumonia, Bacterial
CEFTAROLINE FOSAMIL ACETATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
P9VXV1408Y
Molecule Type:
Small molecule
Molecular Formula:
C24H27N8O11PS4
Molecular Weight:
762.77
AlogP:
-0.11
PSA:
223.24
HBD:
4.0
HBA:
#RotB:
11.0
Source:
LURASIDONE
(2010)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
LURASIDONE
×
Maximum Phase:
4
First Approval:
2010
UNII:
22IC88528T
Molecule Type:
Small molecule
Molecular Formula:
C28H36N4O2S
Molecular Weight:
492.69
AlogP:
4.26
PSA:
56.75
HBD:
0.0
HBA:
#RotB:
5.0
Source:
CABAZITAXEL
(2010)
Small molecule
Tubulin inhibitor
INJECTION; INTRAVENOUS; IV (INFUSION)
Approved
Neoplasms; Prostatic Neoplasms
CABAZITAXEL
×
Maximum Phase:
4
First Approval:
2010
UNII:
51F690397J
Molecule Type:
Small molecule
Molecular Formula:
C45H57NO14
Molecular Weight:
835.94
AlogP:
4.57
PSA:
202.45
HBD:
3.0
HBA:
#RotB:
10.0
Source:
BOSUTINIB
(2010)
Small molecule
Bcr/Abl fusion protein
Unknown
Approved
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms
BOSUTINIB
×
Maximum Phase:
4
First Approval:
2010
UNII:
5018V4AEZ0
Molecule Type:
Small molecule
Molecular Formula:
C26H29Cl2N5O3
Molecular Weight:
530.46
AlogP:
5.19
PSA:
82.88
HBD:
1.0
HBA:
#RotB:
9.0
Source:
FINGOLIMOD HYDROCHLORIDE
(2010)
Small molecule
Sphingosine 1-phosphate receptor agonist
ORAL
Approved
Multiple Sclerosis
FINGOLIMOD HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2010
UNII:
G926EC510T
Molecule Type:
Small molecule
Molecular Formula:
C19H34ClNO2
Molecular Weight:
343.94
AlogP:
3.2
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
12.0
Source:
1
2
…
59
60
61
62
63
64
65
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA